隔脊髓切除术
医学
心脏病学
内科学
梗阻性肥厚性心肌病
肥厚性心肌病
二尖瓣
二尖瓣反流
梗阻性心肌病
二尖瓣反流
金标准(测试)
体外循环
心间隔
二尖瓣置换术
酒精间隔消融
心脏外科
二尖瓣修补术
主动脉瓣反流
外科
相伴的
心肌病
还原(数学)
压力过载
作者
Xiang Wei,Jing Fang,Song Wan
出处
期刊:Circulation
[Lippincott Williams & Wilkins]
日期:2026-11-16
卷期号:154 (20): 2031-2037
被引量:1
标识
DOI:10.1161/circulationaha.126.080166
摘要
Hypertrophic cardiomyopathy (HCM) is a prevalent heterogenous genetic cardiac disorder. In the cardiac myosin inhibitor era, the guideline-directed management of HCM remains an emerging frontier worldwide. Septal myectomy has been the gold standard treatment option for obstructive HCM over the past 60 years. However, the complexity of this procedure and required expertise (and lack of qualified training) have limited its success and availability beyond high-volume HCM centers. Transapical beating-heart septal myectomy (TA-BSM), a newly developed innovative technique, simplifies conventional septal myectomy by eliminating the need for sternotomy, cardiopulmonary bypass, and aortotomy. Most important, the inclusion of real-time intraoperative echocardiographic guidance and evaluation makes TA-BSM safer, more precise, cost-effective, and reproducible. The apparent advantages of TA-BSM, including substantial reductions in surgical trauma and operating times and much faster postoperative recovery in patients with obstructive HCM, are encouraging. TA-BSM is particularly feasible in patients with long-segment obstruction, or small aortic valve annulus, or in those who had undergone previous cardiac operations. The frequent resolution of systolic anterior motion and associated mitral regurgitation after TA-BSM, without concomitant mitral valve intervention, highlights the central role of intraoperative echocardiography and close surgeon-echocardiographer collaboration in achieving optimal procedural outcomes. Further multicenter evaluation of TA-BSM will help define its role among septal reduction strategies for patients with obstructive HCM.
科研通智能强力驱动
Strongly Powered by AbleSci AI